Jazz Pharmaceuticals vs ONCOMATRYX
Jazz Pharmaceuticals vs ONCOMATRYX, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Jazz Pharmaceuticals is on 24/100 and ONCOMATRYX on 50/100.
Where each one leads
Jazz Pharmaceuticals
- domain rating: 76/100 against 26/100
- funding raised: $265M against $107M
ONCOMATRYX
- our overall score: 50/100 against 24/100
At a glance
| Measure | Jazz Pharmaceuticals | ONCOMATRYX |
|---|---|---|
| What it is | Global biopharmaceutical company focused on oncology and neuroscience treatments. | Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies. |
| Category | Biotechnology, Pharmaceuticals, Life Sciences | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Pharmaceuticals | Services |
| Founded | 2003 | 2009 |
| Headquarters | Dublin, Ireland | Derio, Spain |
| Status | Active | Active |
Size, funding and growth
| Measure | Jazz Pharmaceuticals | ONCOMATRYX |
|---|---|---|
| Employees | Not published | 36 |
| Total funding | $265M | $107M |
| Latest round | Post IPO | Funding Round |
| LinkedIn followers | Not published | 5,170 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Jazz Pharmaceuticals | ONCOMATRYX |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 24/100 | 50/100 |
| Traction | 40/100 | 56/100 |
| Team | 70/100 | 30/100 |
| Community | 8/100 | Not published |
| Search visibility | 6/100 | 37/100 |
| Quality | 15/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (33/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 76/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Jazz Pharmaceuticals | ONCOMATRYX |
|---|---|---|
| Hosting | AWS | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Not detected | Google Analytics 4 |
| Open source | Yes | No |
Jazz Pharmaceuticals vs ONCOMATRYX: common questions
Which is better, Jazz Pharmaceuticals or ONCOMATRYX?
On our 0-100 score ONCOMATRYX rates higher (50/100 against 24/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Jazz Pharmaceuticals and ONCOMATRYX compare on the numbers?
Jazz Pharmaceuticals leads on domain rating (76/100 against 26/100), funding raised ($265M against $107M). ONCOMATRYX leads on our overall score (50/100 against 24/100).
Read the full Jazz Pharmaceuticals review and pricing or the ONCOMATRYX review and pricing. You can also browse other Jazz Pharmaceuticals alternatives we track.